Viewing Study NCT03009058

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:01 AM
Ignite Modification Date: 2026-02-22 @ 7:03 PM
Study NCT ID: NCT03009058
Status: TERMINATED
Last Update Posted: 2024-11-25
First Post: 2016-12-16
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer
Sponsor: Immodulon Therapeutics Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Unresectable cancer View
None pancreatic View
None melanoma View
None breast View
None lung View
None colorectal View
None cholangio View
None sarcoma View